Advanced Biotherapy Inc Com ADVB 深 滬
等待開盤 11-26 09:30:00 美东时间
0.42
-0.004
-0.94%
華盛通- 最 高0.448
- 今 開0.448
- 成交量 9.74万股
- 最 低 0.4175
- 昨 收 0.424
- 總市值 908.88万
- 52周最高 4.10
- 市盈率 靜 --
- 換手率 0.45%
- 52周最低 0.3432
- 委 比 64.71%
- 總股本 2164.00万
- 歷史最高 4.10
- 量 比 0.28
- 振 幅 7.19%
- 歷史最低 0.3432
- 每 手 1
- 風險率 1.09%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多12 Health Care Stocks Moving In Monday's Intraday Session
Gainers Advanced Biomed (NASDAQ:ADVB) stock rose 29.6% to $0.48 during Monday'...
11-25 01:05
Advanced Biomed Q1 EPS $(0.02) Down From $(0.01) YoY
Advanced Biomed (NASDAQ:ADVB) reported quarterly losses of $(0.02) per share. This is a 100 percent decrease over losses of $(0.01) per share from the same period last year.
11-20 08:00
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers MSP Recovery (NASDAQ:MSPR) shares rose 93.0% to $0.61 during Tuesday's...
11-11 20:07
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Aditxt (NASDAQ:ADTX) shares increased by 28.3% to $0.89 during Thursda...
10-10 05:06
Advanced Biomed Q4 EPS $(0.03) Up From $(0.04) YoY
Advanced Biomed (NASDAQ:ADVB) reported quarterly losses of $(0.03) per share. This is a 25 percent increase over losses of $(0.04) per share from the same period last year.
10-09 05:37
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers Enanta Pharma (NASDAQ: ENTA) stock rose 15.6% to $9.13 during Friday's after-market session. The market value of their outstanding shares is at $165.6 million.
09-27 05:06
Advanced Biomed Launches A+PerfusC™ Platform
The latest update is out from Advanced Biomed Inc. ( ($ADVB) ). On September 19...
09-20 05:01
Advanced Biomed Launches A+PerfusC System Designed To Replicate Human Physiological Conditions In Vitro
Advanced Biomed Inc. (NASDAQ:ADVB) (the "Company", "Advanced Biomed"), a biotechnology company focused on developing and commercializing innovative biomedical products for precision medicine and advanced diagnostics,
09-19 20:34
Advanced Biomed Inc. Announces Launch of A+PerfusC™ – Integrated Perfusion 3D Cell Culture Platform for Precision Medicine and Drug Discovery
Advanced Biomed Inc. has launched the A+PerfusC™ system, a compact, automated 3D cell culture incubator designed to replicate human physiological conditions. The system features 8 independent channels per plate, supports up to 4,800 tumor spheroids, and can be integrated with microscopy platforms for real-time observation. It enables continuous culture for up to 12 days, enhancing cell viability and drug response predictability. Applications incl...
09-19 12:30
Advanced Biomed Receives Nasdaq Delisting Notice
The latest announcement is out from Advanced Biomed Inc. ( ($ADVB) ). On July 1...
07-25 04:43
